Back to search

Article

Highly-selective μ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

2020-03-02

Abstract excerpt

<title>Abstract</title> <p>Objectives Dopamine-replacement utilizing L-DOPA is still the mainstay treatment for Parkinson’s disease (PD), but often leads to development of L-DOPA-induced dyskinesia (LID), which can be as debilitating as the motor deficits. There is currently no satisfactory pharmacological adjunct therapy. The endogenous opioid peptides enkephalin and dynorphin are important co-transmitters in th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c59b167-2bf1-5605-978f-fc959d4c9814
DOI
10.21203/rs.2.21906/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Highly-selective μ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelDOI 10.21203/rs.2.21906/v3
Select a neighboring publication to make it the new centre.